Medtronic Cardiac Rhythmic Disease Management - Nugra Karsera

Medtronic Cardiac Rhythmic Disease Management

Source: Medtronic Website	Vitatron - G20 SR Diagnose AT/AF Compass provides the clear, concise information you need to help detect atrial arrhythmias early. Its full array of capabilities can then guide your therapy decision making. Prevent Reduced Ventricular Pacing+ reduces unnecessary RV pacing to less than 20%.1 This is essential to your patients because minimizing unnecessary RV pacing reduces the risk of AF, heart failure hospitalization and mortality.2-4 Treat The G-series pacing algorithms not only recognize atrial tachyarrhythmias in your patients, they also initiate therapies to manage those arrhythmias and help alleviate symptoms: Atrial Preference Pacing (APP) Post Mode Switch Overdrive Pacing (PMOP) Conducted AF Response Rate Drop Response – When syncope is the result of carotid sinus syndrome or vasovagal syncope, the G-series pacemaker recognizes the imminent faint and responds by pacing at an increased rate. This flexible recognition algorithm may help to alleviate symptoms in your patients and prevent their syncope altogether. More information here.
Source: Medtronic Website	Sphera SR - SPSR01 Physical characteristics Size (H x W x D) - 40.2 mm x 42.9 mm x 7.5 mm Battery - Radiopaque ID PHX, Type Lithium-iodine, Voltage 2.8 V Average Projected Capacity - 0.92 Ah Longevity (years) - 8.7 Brief Statement See the MRI SureScan™ Technical Manual before performing an MRI Scan and Device Manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. More information here.
Source: Medtronic Website	Sphera DR - SPDRL1 Physical characteristics Size (H x W x D) - 45.4 mm x 52.3 mm x 7.5 mm Battery - Radiopaque ID PHX, Type Lithium-iodine, Voltage 2.8 V Average Projected Capacity - 1.6 Ah Longevity (years) - 11.1 Brief Statement See the MRI SureScan™ Technical Manual before performing an MRI Scan and Device Manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. More information here.
Source: Medtronic Website	Azure DR - W2DR01 The Azure™ pacemaker is equipped with BlueSync™ technology and is compatible with MyCareLink Heart mobile app — the latest innovation from Medtronic in remote monitoring. If Azure detects changes in your heart, it wirelessly and securely transfers your heart device information to your clinic. Azure pacemaker is safe in the MRI environment when specific conditions are met, and offers exclusive algorithms to accurately detect and reduce the likelihood of atrial fibrillation. Model numbers: W1DR01, W1SR01, W3DR01, W3SR01 More information here.
Source: Medtronic Website	Mirro ICD VR Automatic - Simple to Use Continuously adapts key device parameters to ensure the therapies are optimized. - TherapyGuide - Auto-adjusting sensitivity (RV) - CareAlert sounds incl. Lead Integrity Alert (LIA) - CareLink connectivity (Medtronic CareLink is forward compatible; release date to be confirmed) - Wireless telemetry VT/VF Management Therapies and algorithms to help manage ventricular tachyarrhythmias. - Ventricular cardioversion/defibrillation - Ventricular antitachycardia pacing (ATP) - ChargeSaver with ATP Before and During Charging - Smart Mode - Programmable RV sensing polarity - Programmable HV shocking vectors - 3 detection zones allowing VF and FVT zone overlap - SVT Discriminators Wavelet, Stability, Onset - Wavelet programmable to discriminate SVT in VF zone Mirro MRI™ ICD is approved for use in the MR environment, when MR conditions for use are met. MRI SureScan™ devices have simple scanning conditions, including: No MRI exclusion zone SureScan devices and leads work in any combination 1.5T and 3T full body scanning across the portfolio More information here.
Source: Medtronic Website	Mirro ICD DR Automatic - Simple to Use Continuously adapts key device parameters to ensure the therapies are optimized. - TherapyGuide - Auto-adjusting sensitivity (RV) - CareAlert sounds incl. Lead Integrity Alert (LIA) - CareLink connectivity (Medtronic CareLink is forward compatible; release date to be confirmed) - Wireless telemetry VT/VF Management Therapies and algorithms to help manage ventricular tachyarrhythmias. - Ventricular cardioversion/defibrillation - Ventricular antitachycardia pacing (ATP) - ChargeSaver with ATP Before and During Charging - Smart Mode - Programmable RV sensing polarity - Programmable HV shocking vectors - 3 detection zones allowing VF and FVT zone overlap - SVT Discriminators Wavelet, Stability, Onset - Wavelet programmable to discriminate SVT in VF zone Mirro MRI™ ICD is approved for use in the MR environment, when MR conditions for use are met. MRI SureScan™ devices have simple scanning conditions, including: No MRI exclusion zone SureScan devices and leads work in any combination 1.5T and 3T full body scanning across the portfolio More information here.
Source: Medtronic Website	Solara CRTP Personalised CRT + Expanded MRI Access Achieving optimal response can be challenging. Our Solara CRT-Ps offer tools to personalise CRT. These devices are safe for use in the MRI environment when specific conditions are met. The quad model features: MRI SureScan™ Technology Attain Performa™ Advanced Quadripolar Lead and VectorExpress™ LV Automated Test PhysioCurve™ Design OptiVol™ 2.0 Fluid Status Monitoring MyCareLink Heart™ Mobile App The non-quad model features: MRI SureScan™ Technology PhysioCurve™ Design OptiVol™ 2.0 Fluid Status Monitoring MyCareLink Heart™ Mobile App More information here.
Source: Medtronic Website	Serena CRTP - W4TR05 Serena™ CRT-Ps are enabled with BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring. These devices include an exclusive algorithm to manage atrial fibrillation (AF). PhysioCurve Design for Patient Comfort Tapered at the head and bottom of device to reduce skin pressure and promote patient comfort. Designed with lead wrap in mind — landing area to minimize additional stresses on the lead.1 More information here.
Source: Medtronic Website	Percepta CRTP -W4TR04 Percepta™ CRT-Ps are enabled with BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring. These devices include exclusive algorithms to optimize CRT and manage atrial fibrillation (AF). Enhanced Longevity Percepta™ Quad CRT-P MRI SureScan™ estimated longevity is greater than that of Viva™ CRT-P.† Physiocurve™ Design for Patient Comfort Tapered at the head and bottom of device to reduce skin pressure and promote patient comfort. Designed with lead wrap in mind — landing area to minimize additional stresses on the lead.4 Exclusive algorithms to manage HF CareAlert Notifications More information here.
Source: Medtronic Website	Compia CRT-D MRI The Medtronic Model DTMC1QQ Compia MRI Quad dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (CRT-D) is a multiprogrammable cardiac device that monitors and regulates the patient’s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; and ventricular tachyarrhythmia therapies. The device can detect ventricular tachycardia and ventricular fibrillation (VT/VF) automatically and provide treatment with defibrillation, cardioversion, and antitachycardia pacing therapies. The device can also detect atrial tachycardia and atrial fibrillation (AT/AF) automatically. Simultaneous or sequential biventricular pacing is used to provide patients with cardiac resynchronization therapy. The device responds to bradyarrhythmias by providing bradycardia pacing therapies. The Compia MRI Quad system is indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias and for providing cardiac resynchronization therapy in heart failure patients on stable, optimal heart failure medical therapy if indicated, and meet any of the following classifications: New York Heart Association (NYHA) Functional Class III or IV and who have a left ventricular ejection fraction ≤35% and a prolonged QRS duration Left bundle branch block (LBBB) with a QRS duration ≥130 ms, left ventricular ejection fraction ≤30%, and NYHA Functional Class II NYHA Functional Class I, II, or III and who have left ventricular ejection fraction ≤50% and atrioventricular block (AV block) that are expected to require a high percentage of ventricular pacing that cannot be managed with algorithms to minimize right ventricular pacing. Optimization of heart failure medical therapy that is limited due to AV block or the urgent need for pacing should be done post implant More information here.
Source: Medtronic Website	Micra™ VR MC1VR01 Unlike most pacemakers that are placed in the patient's chest with leads running to the heart, Micra is implanted directly into the patient’s heart. Less invasive — Micra is placed in the heart via a vein in the leg, thus no chest incision, scar, or bump that results from conventional pacemakers. Self-contained — Micra is completely self-contained within the heart. It eliminates potential medical complications arising from a chest incision and from wires running from a conventional pacemaker into the heart. Small — Micra is 93% smaller than conventional pacemakers, about the size of a large vitamin capsule Micra Model MC1VR01 is indicated for use in patients who have experienced one or more of the following conditions: symptomatic paroxysmal or permanent high-grade AV block in the presence of AF symptomatic paroxysmal or permanent high-grade AV block in the absence of AF, as an alternative to dual chamber pacing, when atrial lead placement is considered difficult, high risk, or not deemed necessary for effective therapy symptomatic bradycardia-tachycardia syndrome or sinus node dysfunction (sinus bradycardia or sinus pauses), as an alternative to atrial or dual chamber pacing, when atrial lead placement is considered difficult, high risk, or not deemed necessary for effective therapy Rate-responsive pacing is indicated to provide increased heart rate appropriate to increasing levels of activity. More information here.
Source: Medtronic Website	Micra™ AV MC1AVR1 AV SYNCHRONY REIMAGINED Accelerometer-based mechanical atrial sensing – Median AV synchrony at rest in complete AV block patients with normal sinus rhythm: 94.3% – Mean AV synchrony increased from 26.8% during VVI pacing to 89.2% – Stroke volume improvement: 8.8% Dynamic sensing that adjusts pacing based on the mechanical atrial contraction. New, integrated circuitry capable of sustaining new AV synchrony functionality1 11 new algorithms Estimated average battery longevity of 8–13 years,dependent on the patient's degree of AV block9,1 More information here.
Source: Medtronic Website	Tyrx - CMRM6133INT TYRX™ Neuro Absorbable Antibacterial Envelope. The only* fully absorbable antibacterial envelope for use with implantable neurostimulators. The TYRX™ Absorbable Antibacterial Envelope is a fully absorbable sterile prosthesis designed to hold an Implantable Neurostimulator (INS) securely in place to create a stable environment when implanted in the body. The TYRX™ bioabsorbable polymer coating contains antimicrobial agents Minocycline and Rifampicin each in concentrations of 102 ug/cm2 More information here.
Source: Medtronic Website	Reveal XT Insertable Cardiac Monitor - 9529 The Medtronic Reveal XT Insertable Cardiac Monitor is a programmable device that continuously monitors a patient’s ECG and other physiological parameters. The Reveal XT records cardiac information in response to automatically detected arrhythmias and patient activation. The Reveal XT is designed to automatically record the occurrence of arrhythmias in a patient. Arrhythmia may be classified as atrial tachyarrhythmia/atrial fibrillation (AT/AF), bradyarrhythmia, asystole, or (fast) ventricular tachyarrhythmia. In addition, the Reveal XT can be activated by the patient to record cardiac rhythm during symptomatic episodes. More information here.
Source: Medtronic Website	Reveal LINQ - LNQ11 The Medtronic Reveal LINQ ICM is a programmable device that continuously monitors a patient’s ECG and other physiological parameters. The device records cardiac information in response to automatically detected arrhythmias and patient activation. The device is designed to record the occurrence of an arrhythmia in a patient automatically. Arrhythmias may be classified as tachyarrhythmia, bradyarrhythmia, pause, atrial tachyarrhythmia, or atrial fibrillation. In addition, while experiencing or immediately after a symptomatic event, the patient can activate the recording of cardiac information in the ICM. Discreet – The Reveal LINQ ICM is not visible in most patients. Easy – The MyCareLink Monitor uses a cellular signal and a power outlet. MRI Compatible – The Reveal LINQ ICM is safe for use in an MRI setting. 3 Years – The Reveal LINQ ICM detects abnormal heart rhythms for up to 3 years More information here.
Source: Medtronic Website	Single Chamber Temporary External Pacemaker - 53401 Introducing temporary external pacemakers Models 53401, our complete EPG portfolio and the next generation of temporary external pacemakers for managing bradycardia. Both Models include easily configurable features, enhanced user interface, and improved low battery indicator. More information here.
Source: Medtronic Website	Dual Chamber Temporary External Pacemaker - 5392 Introducing temporary external pacemakers Models 5392, our complete EPG portfolio and the next generation of temporary external pacemakers for managing bradycardia. Both Models include easily configurable features, enhanced user interface, and improved low battery indicator. More information here.